{"id":"octreotide-capsules","safety":{"commonSideEffects":[{"rate":"10-30%","effect":"Diarrhea"},{"rate":"10-30%","effect":"Nausea"},{"rate":"5-20%","effect":"Abdominal pain"},{"rate":"5-20%","effect":"Headache"},{"rate":"5-20%","effect":"Injection site reaction"}]},"_chembl":{"chemblId":"CHEMBL1680","moleculeType":"Protein","molecularWeight":"1019.26"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to somatostatin receptors on the surface of cells, octreotide reduces the secretion of growth hormone and other hormones, such as insulin and gastrin. This can help to control symptoms associated with acromegaly and other conditions.","oneSentence":"Octreotide capsules mimic the natural hormone somatostatin to decrease production of growth hormone and other hormones.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:23:55.540Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acromegaly"},{"name":"Gastrointestinal carcinoid syndrome"},{"name":"Hormone-secreting tumors"}]},"trialDetails":[{"nctId":"NCT03792555","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)","status":"COMPLETED","sponsor":"Crinetics Pharmaceuticals Inc.","startDate":"2019-03-11","conditions":"Acromegaly","enrollment":13},{"nctId":"NCT02685709","phase":"PHASE3","title":"Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly","status":"COMPLETED","sponsor":"Chiasma, Inc.","startDate":"2016-02","conditions":"Acromegaly","enrollment":146},{"nctId":"NCT03252353","phase":"PHASE3","title":"Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly","status":"UNKNOWN","sponsor":"Chiasma, Inc.","startDate":"2017-09-01","conditions":"Acromegaly","enrollment":56},{"nctId":"NCT03798912","phase":"PHASE1","title":"A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform","status":"COMPLETED","sponsor":"RANI Therapeutics","startDate":"2019-07-09","conditions":"Healthy Volunteers","enrollment":62},{"nctId":"NCT00853047","phase":"PHASE2","title":"Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy","status":"COMPLETED","sponsor":"Lexicon Pharmaceuticals","startDate":"2009-03","conditions":"Carcinoid Syndrome","enrollment":23},{"nctId":"NCT01412424","phase":"PHASE3","title":"Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly","status":"COMPLETED","sponsor":"Chiasma, Inc.","startDate":"2012-03","conditions":"Acromegaly","enrollment":155},{"nctId":"NCT01048086","phase":"PHASE2","title":"90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)","status":"WITHDRAWN","sponsor":"University of Iowa","startDate":"2009-06","conditions":"Neuroblastoma, Neuroendocrine Tumor","enrollment":""},{"nctId":"NCT00789841","phase":"","title":"Gastrointestinal Motility in Patients With Neuroendocrine Tumors","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2008-09","conditions":"Neuroendocrine Tumor","enrollment":13}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":18,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["MYCAPSSA","Injection SRLs","MYCAPSSA™","Formerly known as Octreolin™"],"phase":"phase_3","status":"active","brandName":"octreotide capsules","genericName":"octreotide capsules","companyName":"Chiasma, Inc.","companyId":"chiasma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Octreotide capsules mimic the natural hormone somatostatin to decrease production of growth hormone and other hormones. Used for Acromegaly, Gastrointestinal carcinoid syndrome, Hormone-secreting tumors.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}